The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The relative value of anti-Müllerian hormone to predict premature menopause in patients receiving adjuvant chemotherapy for breast cancer: Results from the OPTION trial.
Robert C. F. Leonard
No relevant relationships to disclose
Douglas Adamson
No relevant relationships to disclose
Gianfilippo Bertelli
No relevant relationships to disclose
Michelle McLinden
No relevant relationships to disclose
Nan Haiying
No relevant relationships to disclose
Joanna Dunlop
No relevant relationships to disclose
Janine Mansi
No relevant relationships to disclose
Robert Edward Coleman
No relevant relationships to disclose
Gerry Thomas
No relevant relationships to disclose
Richard Anderson
No relevant relationships to disclose